BioCatalyst

AAA617, 68Ga-PSMA-11 — catalyst calendar

1 verified catalyst event(s) referencing AAA617, 68Ga-PSMA-11, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-14
in 4mo
ESTIMATED
 READOUT
Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moder
Phase 2 · Metastatic Castration-Resistant Prostate Cancer (mCRPC)
 NVS NOVARTIS AG AAA617, 68Ga-PSMA-11 ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.